SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" or "Vaxart") today announced its business update and financial results for the first quarter of ...

An artificial tear solution is one of five ophthalmic products now under recall due to lapses in manufacturing processes, according to the FDA. The voluntary recalls were initiated by BRS Analytical ...

Cytokinetics' PDUFA date for aficamten was extended to December 26th of 2025, due to the FDA's need to review a submitted ...

The U.S. health secretary has railed against the fluoridation of drinking water, referring to fluoride as a "dangerous neurotoxin." ...

U.S. health regulators announced plans Tuesday to phase out fluoride-containing supplements sometimes used to strengthen ...

New research shows that toothpaste is widely contaminated with toxic heavy metals including lead, mercury, arsenic and ...

Tucked inside President Trump's executive order on drug pricing is a sentence that appears to threaten the FDA could yank ...

The 86 products were commonly available and for sale at retailers and food service locations, including convenience stores, ...

A Seattle-area company that offers drug-free therapy for anxiety and panic attacks has landed FDA approval for treating teens ...

FDA seeking 'aggressive' adoption of AI . The FDA announced an "aggressive timeline" to deploy artificial intelligence ...

While venture funding is rising, federal policy upheaval may affect women’s health research more acutely than other fields, ...